GENEXPERT
Device
Cepheid
Total Payments
$1.9M
Transactions
326
Doctors
184
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $252,828 | 69 | 15 |
| 2020 | $883,086 | 140 | 97 |
| 2019 | $505,108 | 106 | 83 |
| 2018 | $293,499 | 11 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 33 | 90.5% |
| Consulting Fee | $134,383 | 118 | 6.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $25,800 | 52 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,194 | 6 | 0.8% |
| Food and Beverage | $6,151 | 111 | 0.3% |
| Travel and Lodging | $2,339 | 6 | 0.1% |
Payments by Type
Research
$1.8M
33 transactions
General
$183,866
293 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Near-Patient Testing | Cepheid | $235,450 | 0 |
| Xpert | Cepheid | $150,035 | 0 |
| Evaluation of Xpert Bacterial vs Viral Assay | Cepheid | $91,000 | 0 |
| Open Systems Reagents Evaluation | Cepheid | $84,400 | 0 |
| Evaluating FluRSV Assay | Cepheid | $82,600 | 0 |
| Xpert Xpress MVP Test | Cepheid | $64,690 | 0 |
| CONTAM Study | Cepheid | $64,400 | 0 |
| Cartridge-based next-generation sequencing library preparation optimized for the Oxford Nanopore platform | Cepheid | $64,000 | 0 |
| Remote Testing Using Xpert Xpress Flu/RSV | Cepheid | $58,000 | 0 |
| Sample Extraction | Cepheid | $49,995 | 0 |
| Xpert Breast Cancer STRAT4 Verification Study | Cepheid | $49,995 | 0 |
| MDRO | Cepheid | $45,000 | 0 |
| Xpert SARS-CoV-2 | Cepheid | $35,000 | 0 |
| Optimizing Detection of C.diff | Cepheid | $34,400 | 0 |
| Evaluation of Xpert SARS-CoV-2 | Cepheid | $32,450 | 1 |
| UCLA - Covenant House | Cepheid | $25,000 | 0 |
| Yale School of Medicine | Cepheid | $25,000 | 0 |
| Evaluation of Xpert C. difficileEpi Assay Using Rectal Swab Samples in Asymptomatic Patients Alpha Study | Cepheid | $7,750 | 0 |
Top Doctors Receiving Payments for GENEXPERT — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Fort Myers, FL | $413.00 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $413.00 | 1 |
| , M.D | Internal Medicine | San Mateo, CA | $412.50 | 1 |
| , MD | Family Medicine | Powell, OH | $412.50 | 1 |
| , D.O | Family Medicine | Flagstaff, AZ | $412.50 | 1 |
| , M.D | Internal Medicine | Greenwood Village, CO | $412.50 | 1 |
| , MD | Internal Medicine | West Valley City, UT | $412.50 | 1 |
| Wayne Chen | — | Los Angeles, CA | $412.50 | 1 |
| Roger Muller | — | Tigard, OR | $412.50 | 1 |
| , MD | Gastroenterology | Skokie, IL | $412.50 | 1 |
| , MD | Urology | New York, NY | $407.00 | 1 |
| , M.D | Orthopaedic Surgery | Brooklyn, NY | $394.00 | 1 |
| , M.D | Medical Oncology | Baltimore, MD | $393.00 | 1 |
| , M.D | Cytopathology | Jamaica Plain, MA | $387.00 | 1 |
| , MD | Internal Medicine | Santa Rosa, CA | $381.00 | 1 |
| , MD | Internal Medicine | Chicago, IL | $379.00 | 1 |
| , MD | Hematology & Oncology | Mt Sterling, KY | $360.00 | 1 |
| , M.D | Neurology | Stanford, CA | $353.00 | 1 |
| , MD | Ophthalmology | Columbia, SC | $350.00 | 1 |
| , M.D | Pulmonary Disease | Arcadia, CA | $347.00 | 1 |
| , MD PHD | Infectious Disease | Providence, RI | $341.00 | 1 |
| , MD,PHD | Hematology & Oncology | Boston, MA | $338.00 | 1 |
| , M.D | Dermatology | Newtown, CT | $338.00 | 1 |
| , M.D | Hematology | Maryville, TN | $333.00 | 1 |
| , M.D | Infectious Disease | San Francisco, CA | $331.00 | 1 |
About GENEXPERT
GENEXPERT is a device associated with $1.9M in payments to 184 healthcare providers, recorded across 326 transactions in the CMS Open Payments database. The primary manufacturer is Cepheid.
Payment data is available from 2018 to 2021. In 2021, $252,828 was paid across 69 transactions to 15 doctors.
The most common payment nature for GENEXPERT is "Unspecified" ($1.8M, 90.5% of total).
GENEXPERT is associated with 18 research studies, including "Near-Patient Testing" ($235,450).